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The group A streptococcus is an important bacterial pathogen because it
causes suppurative infections that may lead to the serious sequelae of glomeru-
lonephritis or rheumatic fever . Clinical isolates of group A streptococci have M
protein on their surface, and these organisms are able to resist phagocytosis in
laboratory tests (1) . The human host responds to streptococcal infection by
elaborating antibodies to the M protein, some of which are protective against
subsequent infection by streptococci of the same type (2). For these reasons, the
M protein has been considered a major virulence factor for the group A
streptococcus . Currently, over 70 different antigenic types of M protein have
been found in nature, and this serologic diversity apparently accounts for the
ability of an individual host to be infected with different strains of group A
streptococci .
The M protein is found as a fibrillar molecule on the surface of the strepto-
coccus . It is composed of coiled-coil dimers with high a-helical content (3) and is
anchored to the streptococcal cell surface by its carboxy terminus (4, 5) . Among
streptococcal strains of different M serotypes, the molecular weight of the M
protein molecule varies by over 40,000, and even within a single serologic M
type, M6, the size diversity observed for M proteins is almost that great (6) .
However, using the cloned gene that encodes type 6M protein (emm6) as a DNA
probe, we observed homology with strains representative of 56 differentM types
and three that are nontypable (7) . This homology resides primarily in the
carboxy-terminal part of the molecule, as shown by additional hybridization
studies (8) .
The DNA hybridization results revealed a group A streptococcal strain
(T28/51/4) that is probably deleted for all M protein-related sequences because
it does not hybridize with the emm6 probe, although an M+ strain derived from
the same clinical isolate does hybridize (7) . Transformation of this deletion
mutant allowed us to determine that the emm6 gene we have cloned is sufficient
to provide all the genetic information to convert the M- deletion strain to an
M6' strain .
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FIGURE 1 .
￿
Restriction map of pJRS50 showing the derivation of the different fragments .
Both lightly stippled Barn HI-Hind III fragments (one of which carries the Cm determinant)
are from pACYC184 (11), the striped Hind III-Ava I fragment is from pVA380-1 (12), the
darkly stippled Ava I-Hind III fragment carries the Em determinant and is from pVA-1 (13),
the black Bam HI-Pst I fragment is from S. pyogenes D471 and includes emm6 (the gene for
type 6 M protein) (14), and the white Pst I-Bam HI fragment is from pUC18 (15) . The
numbers within the circle are kilobase coordinates.
Materials and Methods
Media and Antibiotics .
￿
Chloramphenicol was used at 3 tag/ml for streptococci and 25
tug/ml for Escherichia coli, erythromycin was at 10 or 50 gg/ml for streptococci and 1,000
pg/ml for E. coli, and streptomycin was at 1,000 rig/ml for streptococci . Beef heart
infusion broth (BHI)' (Difco, Detroit, MI) was used for growth of Streptococci sanguis,
THY (Todd-Hewitt yeast extract [6]) sometimes supplemented with defibrinated sheep
blood to give a final concentration of 2%, was used for Streptococcus pyogenes, and LB
(Luria-Bertani broth) (9) was used for E. coli .
Streptococci Strains. S. pyogenes (group A) strain D471 is a streptomycin-resistant
derivative isolated in the laboratory from the M type 6 strain ofThe Rockefeller University
(RU) collection . S. pyogenes strain T28/51/4, from the RU collection, is an M- deletion
derivative (7) obtained by laboratory passage from a clinical isolate expressing type 28M
protein . A strain resistant to 1,000 Ag/ml streptomycin was selected from an overnight
culture of T28/51/4 and named JRS1 . S . sanguis V288 from Dr . F . Macrina, Dept . of
Microbiology, Virginia Commonwealth University (13) is a derivative of strain Challis.
Plasmids .
￿
pVA797 (10), from Macrina, is a conjugative plasmid in which a fragment
ofpVA380-1 was used to replace the erythromycin resistance (Em) determinant of the
transfer-proficient plasmid pIP501 . It carries the chloramphenicol resistance (Cm) deter-
minant of pIP501 .
Construction ofShuttle Vector.
￿
pJRS50 (Fig . 1) is derived from a cointegrate of Macrina's
E . coli-Streptococcus shuttle vector pVA838 (13) and pjRS42.50 (5), which consists of an
Xba I-Pst I DNA fragment, including the emm6 gene from S. pyogenes D471 (14) cloned
into pUC18 (15) . We destroyed the ampicillin resistance determinant of pjRS42.50 by
deleting a Pvu I fragment from the 3-lactamase-encoding region of the piece of DNA
'Abbreviations used in this paper:
￿
BHI, beefheart infusion broth ; Cm, chloramphenicol resistance
determinant; Em, erythromycin resistance determinant ; Sm, streptomycin resistance determinant ;
Tc, tetracycline resistance determinant ; TH, Todd-Hewitt ; THY, Todd-Hewitt yeast extract .SCOTT ET AL.
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derived from pUC 18. The resulting plasmid has two origins for replication in E. coli (from
pUC18 and from pACYC184) and one for replication in streptococci (from pVA380-1, a
cryptic plasmid from S. ferus [12]). It has the Cm gene of pACYC 184 (11), which is not
expressed in streptococci, and the Em gene from pVA-1 (13), which is expressed in both
E. coli and streptococci. Because pjRS42.50 was inserted within the tetracycline (Tc) gene
of pACYC184, the pJRS50 plasmid does not express Tc.
Transformation of S. sanguis (Strain Challis).
￿
S. sanguis strain VA288 (10) was passed
on BHI agar one to two times, and a single colony was used to inoculate BHI containing
erythromycin. This culture was grown overnight at 37 ° C and diluted threefold to fresh
medium containing a 10-fold dilution of heat-inactivated (56°C for 30 min) horse serum
in a side-arm flask. Growth at 37°C with slow shaking was monitored in a colorimeter
(Klett Manufacturing Co., Inc., New York) with a red filter. When the reading rose from
15 to 75 (which takes 2 h), 0.33 ml samples were added to the transforming DNA and
incubated for 1 .5 h at 37°C. Transformants were selected on THY plates containing
erythromycin and chloramphenicol .
Filter Mating between S. sanguis and S. pyogenes.
￿
The procedure of Clewell et al . (16)
was followed. Recombinants were selected by plating on THY with streptomycin (to select
against the donor) and erythromycin (to select for the cointegrate plasmid). The frequency
was ^-6 x 10-a Em recombinants per donor CFU (based on the number of CFU on Em
medium at the time of plating for recombinants). In a control mating using S. sanguis
V288(pVA797) as the donor, there were ^-2 x 10-5 Cm recombinants per donor CFU.
Colony Blot Radioimmunoassay.
￿
This procedure was as described by Scott and Fischetti
(14).
Rotation in Human Blood.
￿
A log-phase Todd Hewitt (TH)-grown culture of S. pyogenes
was diluted to 10-50 CFU and added to heparinized (10 U/ml) human blood. The
mixture was rotated at 37°C for 3 h and survivors were plated in TH blood agar. To
repeat the process, a single colony from the survivors was used as an inoculum for the
next passage.
Southern Blot Analysis.
￿
The procedures of Meinkoth and Wahl (17) was used. Washing
was at conditions equivalent to 34'C below the melting temperature.
Immunofuorescence Assay.
￿
A loopful of a log-phase culture of strain JRS2 in TH broth
containing erythromycin (10 wg/ml) and strains D471 and JRS1 in TH broth were each
spread on a clean glass slide and allowed to dry. The cells were fixed to the slide by
immersion in methanol for 30 s and air dried. 20 tl of rabbit anti-ColiM6 IgG tagged
with fluorescein isothiocyanate (18) was added to the fixed cellsand the slidewas incubated
in a moist chamber for 30 min. The slide was washed in water and the cells were air
dried. A coverslip was placed over a drop of 20% glycerol and the cells were viewed
under a Zeiss fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY).
Western Blot. To quantitate the M protein, Western blots using M6 monoclonal
antibodies l OA I 1 and l OB6 (19) were analyzed as described by Jones et al. (20) on lysin
extracts.
Results
Strategy for Gene Transfer.
￿
Because there is no system for transformation of
S. pyogenes, we decided to use the readily transformable S. sanguis strain Challis
as an intermediate host. A chimeric shuttle vector carrying the emm6 gene,
pJRS50 (Fig. 1), was constructed (see Materials and Methods). Plasmid DNA
extracted from E. coli was used to transform S. sanguis strain V288. Clones
containing the emm6 gene were identified by colony blot immunoassay and the
conjugative plasmid pVA797 was transferred into one of these by mating. This
plasmid is composed of parts of the conjugative plasmid pIP501, which contains
a Cm gene expressed in streptococci, and the small cryptic S. ferus plasmid
pVA380-1 (21). The latter is also present in pJRS50 and provides homology
between the two. Transconjugants were plated on medium containing chloram-1644
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TABLE I
Survival in Human Blood of Strain JRS2 Compared with Its ParentJRS1
The bactericidal assay was performed as originally described by Lancefield (2),
with modifications by Fischetti (22). Human blood (400 gel treated with 10 U/ml
heparin) wasmixed with 100 jI ofa dilution of streptococci and 100 Ul of either
broth or antiserum. Anti-Coli M6 is hyperimmune rabbit antiserum prepared
against M6 protein purified from E. coli (4) and anti-M28 was prepared as
describedby Rotta et al. (23). The mixture was rotated in capped tubes for 5 h
at 37°C and a streptococcal colony count was performed by plating a 100-jul
aliquot.
phenicol to select for pVA797 and erythromycin to select for pJRS50. We
expected pVA797 to form a cointegrate with pJRS50, because they share a
region of homology (Fig. 1) and because the twoare incompatible in streptococci
(21). Such a cointegrate should be transferrable by conjugation because it
contains the entire pVA797 conjugative plasmid.
One S. sanguis Cm Em clone identified in an immunoblot assay as expressing
M protein was used as a donor in filter-mating experiments with an S. pyogenes
recipient. The recipient was a spontaneous streptomycin-resistant mutant QRS1)
derived from theemm-deletion strain T28/51/4 (7). An immunoblot (14) showed
that all five recombinant Em Sm colonies expressed M protein.
Survival in Human Blood.
￿
The ability ofthe streptococcus to survive in human
blood is recognized as a means to measure the presence of M protein on the cell
surface (2). To determine whether the M- strain JRS1 gained the capacity to
resist phagocytosis after acquiring the M6 gene, one of the five recombinant
colonies was rotated in human blood. Although no net growth was observed in
the blood, a number of CFU approximately equal to the number in the inoculum
survived. This was in contrast to the M- control (JRS1) which was killed by
phagocytosis. To enrich for survivors in the recombinant strain, a phagocytosis-
resistant colony was picked and the process was repeated twice. After the final
rotation, a colony was selected for further study and designated JRS2 . As shown
in Table 1, strain JRS2 survived, whereas theJRS1 parent did not.
If emm6 encodes the M6 protein rather than activating a cryptic emm gene,
the reconstitutedJRS2 strain should have only type 6 and not type 28 M protein
on its surface. Opsonization by anti-M antiserum is, for the most part, M type-
specific, so we used this test to check the specificity of the protective M protein
on the surface ofJRS2 . As expected, antiserum to purified M6 protein opsonized
theJRS2 strain to allow phagocytosis, whereas hyperimmune antiserum to type
28 M protein-containing streptococci did not (Table I).
S. pyogenes strain Inoculum
(CFU) Antiserum Colony count
after 5-h rotation
JRS1 58 - 0
96 - 0
JRS2 32 - 424
102 - 752
29 Anti-Coli M6 0
81 Anti-Coli M6 0
29 Anti-M28 800
81 Anti-M28 1,144SCOTT ET AL .
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FIGURE 2 .
￿
Agarose gel of digests of pJRS50 and total cellular DNA fromJRS2 . Lane 1, Pst
I digest of pJRS50 ; lane 2, Pst I digest of totalJRS2 DNA; lane 3, Sal I digest of totalJRS2
DNA; lane 4, Sal I digest of pJRS50 .
Location of the emm6 Gene in the S . pyogenes Recombinant.
￿
To determine the
location of the emm6 gene in the S . pyogenes recipient, total DNA fromJRS2 was
digested with Pst I, which cuts within the pjRS42 .50 part of the plasmid (see
Fig . 1) and with Sal I, which linearizes pJRS50 . An agarose gel revealed the
presence of intact pJRS50 plasmid in strainJRS2 (Fig . 2) . Hybridization of this
gel with a probe consisting of almost the entire emm6 gene (the Nci I/Pvu II
fragment ; see reference 7) confirmed this (data not shown), and indicated that
there was no other DNA homologous with emm6 in this strain . Ifa cointegrate
with the mobilizing plasmid had persisted in the S. pyogenes transconjugant, or if
pJRS50 had integrated into the chromosome, junction fragments between the
plasmid and either pVA797 or the host should have been detectable in both of
these digests. Southern blots with Bam HI and Hind III digests of total JRS2
DNA also indicated that the pjRS42.50 segment of the plasmid had not been
disrupted in strain JRS2 (data not shown) . Thus, the emm6 gene remained on
pJRS50 in the transconjugant and the pJRS50 shuttle plasmid was not in the
form ofa cointegrate with the mobilizing plasmid .
Stability of pJRS50 in S. pyogenes JRS2.
￿
The replicon used by pJRS50 in
streptococcus is derived from a plasmid originating in S . ferus (pVA380-1[13]) .
Furthermore, there is no known stability or partition locus present in pJRS50 .1646
￿
CONVERSION OF M- GROUP A STREPTOCOCCUS TO M'
TABLE II
ELISA Titers ofM6 Antisera before and after Absorption with Strains
D471, JRS2, andJRS]
Sera
Anti-Coli M6
Anti-M6 amino-terminal
ELISA were performed with Coli M6 protein-sensitized microtiter plates as
described previously (25). The antibody titer is the reciprocal of the highest
dilution yielding an OD at 405 nm of 1.0 ± 0.2. Anti-M6 amino-terminal is a
hyperimmunerabbit antiserum prepared against a synthetic peptiderepresenting
the amino-terminal 20 amino acids of the native M6 protein.
Once isolated, strainscontaining pjRS50 have been kept under constant selection
for the erythromycin resistance marker. However, because this resistance is
caused by production of an altered ribosomal RNA (24) which does not turn
over rapidly, many cells in the population that have lost the plasmid with the Em
gene may retain the RNA that makes them resistant to erythromycin. To test
for this, an overnight culture ofJRS2 grown in medium containing 50 ttg/ml
erythromycin was plated on drug-free medium. After overnight incubation, the
plates were replicated to medium containing 50 ttg/ml erythromycin. In several
repeated experiments, about 30% of the colonies were unable to grow on the
drug medium, indicating that the plasmid is unstable in this strain.
Presence of M6 Protein on the Surface ofStrain JRS2.
￿
We used two methods to
test for the presence of M6 protein on the surface of JRS2. In the first test,
strains JRS1 and JRS2 were checked by immunofluorescence with anti-M6
antibodies for the presence of M6 protein on the cell surface. Fluorescence was
seen only with strain JRS2, and in this strain ^-70% of the cells in the culture
fluoresced (data not shown). This correlates with the number of cells that still
retain the plasmid (see above) .
In the second test, absorption of monospecific antibodies was used. In contrast
to strain JRS1, strain JRS2 and M6 strain D471 absorbed M6 antibodies both
from antiserum directed to the whole M6 protein and from an antiserumdirected
to a 20-residue synthetic peptide derived from the amino terminus of this
molecule (Table II). This indicates that the M protein is present on the surface
of the JRS2 strain with its amino terminus intact.
In an indirect bactericidal assay (Table III), M6 strain D471 and strain JRS2
were able to absorb opsonic antibodies from these anti-M6 antisera. Thus, the
determinants necessary for opsonization are present intact on the reconstituted
strain JRS2.
Western blot analysis (data not shown) of M protein extracted from strain
D471 and JRS2 with phage lysin revealed the typical pattern of M protein-
Treatment
Unabsorbed
Absorbed with
D471
JRS2
ELISA titer
25,000
800
1,600
JRS1 25,000
Unabsorbed 6,400
Absorbed with
D471 400
JRS2 800
JRSI 6,400TABLE III
Indirect Bactericidal Assay with M6 Strain D471 Using M6 Opsonic
Antisera Absorbed with Strains D471, JRS2, andJRSI
SCOTT ET AL.
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The indirect bactericidal assayusing M6 strain D471 wasperformedas described
in the legend to Table 1, except that the antiserum was absorbed as indicated
with different streptococcal strains and rotation was continued for only 3 h at
37°C. Forabsorption, overnight TH cultures of streptococci were concentrated
10-fold and heat-killed at 56°C for 45 min. Washed cells were then adjusted to
an OD at 650nm of 1.0 (using an 18-mmtube). Cells (1 .5 ml) were pelleted and
suspended in 300 Ial of antiserum and the mixture was rotated at 4°C for 8 h.
The cells were pelleted again and the serum in the supernatant was reabsorbed
with a similar quantity of cells for a further 18 h at 4°C, after which the
supernatant antiserum waspassed through a 0.22-,um filter.
reactive bands (6) in both strains. Because solubilization of the JRS2 cell wall
with lysin released the M protein, the M molecule appears to be located within
the cell wall fraction . Under these conditions, the M6 molecule extracted from
strain JRS2 appears slightly smaller than that extracted from strain D471 .
Western blots indicated that there was ^-20% as much M6 protein on the surface
ofJRS2 as on D471 .
Production ofOpsonic Antibodies with StrainJRS2.
￿
To determine whetherstrain
JRS2 elicits the production of opsonic antibodies, this strain was used to immunize
two rabbits. Although some variation was observed in the response of the rabbits
to this antigen, sera from both were able to opsonize the M6 strain D471 so that
it was phagocytized in an indirect bactericidal assay (Table IV). Thus, we
conclude that strain JRS2 has the determinants needed to elicit opsonic anti-M6
antibodies .
Discussion
We have developed a technique for introducing genes cloned in E. coli into
the group A streptococcus, which is not transformable. The gene of interest is
first cloned in E. coli in a shuttle vector plasmid that is capable of replicating in
both streptococcus and E. coli. Next, an S. sangius Challis strain carrying both a
conjugative plasmid that has homology with the shuttle vector plasmid and the
shuttle vector is constructed. This S. sanguis strain is then mated with S. pyogenes,
and the conjugative plasmid in the S. sanguis strain mobilizes the shuttle vector.
The resulting S. pyogenes transconjugant contains two plasmids: the shuttle vector
Antiserum
Strain with
which anti-
serum was
absorbed
Colony countafter
rotation
Inoculum: 10
3-h
20
None - 904 1,144
Anti-Coli M6 None 0
D471 736
JRS1 3
JRS2 680
Anti-M6amino-terminal None 19
D471 1,900
JRS1 1
JRS2 3981648
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TABLE IV
Indirect Bactericidal Assay with M6 Strain D471 UsingAntisera
Prepared againstStrainJRS2
Theprocedure was as described in the legend to Table III. To immunize
the rabbits, an overnight culture (500 ml) of strain JRS2 grown in TH
broth containing erythromycin (10 fag/ml) was washed with PBS, pH 7.4,
and heat-killed at 56°C for 30 min in 0.1 the original volume. After two
additional washes, the cells were adjusted to an OD at 650 nm of 1.0. 4
ml was emulsified with an equal volume of CFA and 2.0 ml was injected
subcutaneously at multiple sites in each of two rabbits. At 2-wk intervals,
the rabbits were injected subcutaneously with the same quantity of cells
emulsified in IFAto boosttheimmune response. 7-10 daftereach booster
dose, 20 ml of blood was removed from each rabbit.
and the conjugative plasmid from S. sanguis. We do not know whether a
cointegrate between the two plasmids serves as an intermediate in this conjuga-
tion event. In similar conjugation experiments from S. sanguis to S. Jaecalis,
Smith and Clewell (21) found that transconjugants did not contain a cointegrate
conjugative plasmid. The streptococcalgene we have used is emm6, the structural
gene for type 6 M protein from S. pyogenes strain D471 . The recipient group A
M- strain (JRS1) has a deletion that removes all of the chromosomal region
homologous to emm6 (7). Presumably, if there were homology between the
cloned gene and the S. pyogenes chromosome, the plasmid could be inserted at
this site by homologous recombination. Work in progress will test this hypothesis.
By use of this technique, we have added the emm6 gene to the M deletion
strain JRSI . The introduction of the plasmid with the emm6 gene into JRS1
results in the presence of M protein on its surface and the ability to resist
phagocytosis. We have shown that this is due to the production of M6 protein
and not to reactivation of a possible cryptic defective M28 gene present in the
recipient group A strain by capitalizing on the observation that opsonizing
antibody for group A streptococci is M type-specific . The reconstituted M'
strain JRS2 absorbs M type 6-opsonizing antibody, whereas the JRS1 parent
strain does not. Furthermore, antibody against JRS2 opsonizes type 6 strepto-
cocci.
Both the bactericidal test and the immunofluorescence studies indicate that
the reconstitutedJRS2 strain produces less M protein than D471, the strain from
which emm6 was obtained. The pJRS50 plasmid, which carries emm6, is unstable
in S. pyogenes JRS1 . However, even when this instability is corrected for arith-
metically, JRS2 cells that retain the pJRS50 plasmid appear to have only about
one-third as much M protein per M+ cell as D471 .
Two alternative explanations for the small amount of M protein on JRS2 are
immediately apparent. First, the emm6 gene may be expressed less well from the
Antiserum
Colony count after
Inoculum: 4
3-hrotation
8
None >2,000 >2,000
Anti-Coli M6 13 0
AntiJRS2
Rabbit 2-82 93 47
Rabbit 2-85 204 136shuttle plasmid pjRS50 than from the streptococcal chromosome. pjRS50 ap-
pears to contain the natural promoter for emm6 (26), but, in addition, there are
other promoters 5' to the streptococcal DNA that might read through emm6. If
any of these are used preponderantly, the emm6 gene may not be transcribed
efficiently (promoter occlusion [27]). Second, the emm6 promoter may be regu-
lated by trans-acting factors in the streptococcal cell, and such factors may be
deficient in the JRS1 host. Experiments are in progress to distinguish between
these alternatives.
Summary
An M28-derived group A streptococcal strain deleted for the gene encoding
M protein was converted to M+ by introduction ofa plasmid carrying emm6, the
structural gene for type 6 M protein from strain D471 . The reconstituted M+
strain, JRS2, resists phagocytosis in human blood and is opsonized by anti-M6
hyperimmune serum, but not by anti-M28 serum. Immunofluorescent micros-
copy and ELISA demonstrate the presence of M protein on its surface. In
addition, JRS2 removes opsonic antibodies from hyperimmune rabbit sera gen-
erated by immunization with purified ColiM6 protein and with a synthetic amino-
terminal peptide derived from M6. Immunization ofrabbits withJRS2 generates
opsonic anti-M6 antibodies. These results indicate that the cloned emm6 gene
contains the information necessary to convert a phagocytosis-sensitive strepto-
coccus to phagocytosis resistance. Furthermore, it also contains thedeterminants
for M type specificity and those required to elicit opsonic antibodies. It thus
appears to determine all the traits associated with M protein.
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